Cargando…
Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer
5-Fluorouracil is used in the treatment of colorectal cancer along with oxaliplatin as first line treatment, but it is having lack of site specificity and poor therapeutic effect. Also toxic effects to healthy cells and unavailability of major proportion of drug at the colon region remain as limitat...
Autores principales: | Tummala, Shashank, Satish Kumar, M.N., Prakash, Ashwati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475851/ https://www.ncbi.nlm.nih.gov/pubmed/26106279 http://dx.doi.org/10.1016/j.jsps.2014.11.010 |
Ejemplares similares
-
Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery
por: Raval, Mihir K, et al.
Publicado: (2013) -
Clinical research of intraperitoneal implantation of sustained-release 5-fluorouracil in advanced colorectal cancer
por: Yuan, Hang, et al.
Publicado: (2015) -
Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo
por: Sun, Li, et al.
Publicado: (2017) -
Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
por: Subudhi, M. Biswaranjan, et al.
Publicado: (2015) -
Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants
por: Cong, Duanduan, et al.
Publicado: (2023)